Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
Medical University of South Carolina
Medical University of South Carolina
Ottawa Hospital Research Institute
University of California, San Francisco
Erasme University Hospital
Georgetown University
University of Texas Southwestern Medical Center
Palleos Healthcare GmbH
Eli Lilly and Company
Seoul National University Hospital
University Hospital, Antwerp
HealthPartners Institute
Novartis
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Novartis
SenoRx, Inc.
Novartis
Novartis